
BY NOW, YOU'VE probably heard all about the Apple Vision Pro, the iPhone maker's $3,500 headset to be released next year.
With the Vision Pro, Apple is once again walking a well-trodden path. From the original Google Glass a decade ago, to Microsoft's HoloLens in 2016, to Meta's Quest Pro-now just $999- there have been many attempts by Big Tech to make smart goggles happen.
It's the payoff for years of teases from CEO Tim Cook about Apple's big play in augmented reality (AR), the technology placing digital imagery atop the real world.
Leaders like Cook and Meta's Mark Zuckerberg have repeatedly said over the years that they see AR as one day supplanting the smartphone, enabling people to access their apps, make video calls, get sports scores or directions, and even buy things, just by looking through their lenses. In this vision, whoever nails the AR revolution stands to become the de facto hub for the next wave of computing.
Yet the headset revolution has not happened, at least not in anything resembling the mainstream. Generally speaking, headsets cost too much, do too little for the price, face tough technical limitations, and ultimately make anybody who wears them look like-for lack of a better phrase-a complete goober. Google and Microsoft have both hit turbulence with their respective augmented reality strategies, through winding sagas too long to recount here.
Still, it's rarely wise to bet against Apple, given its track record of entering a market late with products like the iPod and iPhone, and still managing to redefine an entire category. The industry consensus is that if Apple can't do it, nobody can.
This story is from the August - September 2023 edition of Fortune US.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the August - September 2023 edition of Fortune US.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In

The Blackstone Edge
90 DAYS. DOZENS OF INTERVIEWS. BILLIONS ON THE LINE. HOW BLACKSTONE'S CEO-MAKER GETS THE JOB DONE.

When Elon Musk has a really tough job, he turns to Steve Davis. DOGE might do the same.
IT WAS THE FALL OF 2022 when employees at Elon Musk's Boring Company began to notice Steve Davis wasn't around.

ASK ANDY - SHOULD MY STARTUP RAISE MONEY FROM VCS? IF SO, WHICH ONES DO I CHOOSE?
A FRIEND—I’ll call him Allen—spent years bootstrapping his real estate enterprise software company. After a long struggle to get to $1 million in sales, his business recently surged to $10 million, and revenue is now growing 100% year on year.

ELLIOTT HILL - JUST DOING IT
Staffers and brand loyalists cheered when Nike's new CEO came out of retirement to lead the company he has had an “irrational love” for since he began there as an intern. Turning it around will take more than good vibes.

HOW TO PLAN YOUR NEXT $100,000 VACATION
ON AN EXCURSION to the ancient city of Petra, Jordan, clients helicoptered in after-hours so they could tour the ruins alone.

THE BATTLE OVER AG1
Influencers are fighting over it. Scientists scoff at it. But the $100-a-month powder once known as Athletic Greens is only getting more popular.

THE WORKPLACE - GEN ZERS WANT TO BE THEIR OWN BOSS.CAN THE CORPORATE WORLD WOO THEM BACK?
CHASE GALLAGHER WAS 12 years old when he started mowing his neighbors' lawns in Chester County, Pa., for $35 a pop in the summer of 2013. At first the Gen Zer had only two customers, but thanks to some aggressive leafleting, he had 10 clients by the following year.

How much can DOGE do?
Elon Musk and Donald Trump aim to cut as much as $2 trillion in federal spending. It'll be even harder than it sounds.

YOUNG PEOPLE ARE DRINKING LESS ALCOHOL. CAN CEO MICHEL DOUKERIS PERSUADE THEM TO KEEP DRINKING AB INBEV'S BEERS?
SOME TIME AGO, top CEOs at an invitation-only seminar at Harvard Business School were asked to imagine the four crises they would likely confront during their tenure at the top: a health emergency, a geopolitical conflict, an economic downturn, and a trade war.

America's drug middlemen are now a $557 billion industry. Can Trump and his allies 'knock out' PBMs?
IN LATE DECEMBER, President-elect Donald Trump put pharmacy benefit managers, or PBMs, on notice.